Navigation Links
Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
Date:11/19/2010

dar; Merck & Co) or temozolomide alone (the current best standard of care).

Novocure also recently reported results from a successful phase II trial that studied TTF therapy in combination with chemotherapy for advanced non-small cell lung cancer at the European Society of Medical Oncology Congress.

The NovoTTF-100A is an investigational device in the United States and has not been approved by the U.S. Food and Drug Administration (FDA) for sale in the US for any use. Results of this phase III trial for recurrent glioblastoma patients have been submitted in a premarket approval application, which is under review by FDA. Novocure currently has CE Mark for the NovoTTF-100A and the treatment is available to patients in Europe.


'/>"/>

Contact: Frank Leonard
frank@novo-cure.com
917-656-3518
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Professor John Shine wins 2010 Prime Ministers Prize for Science
2. CancerCare names Jefferson professor Physician of the Year
3. Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize
4. UT professor defines play, discovers even turtles need recess
5. Virginia Tech professor discovers new TB pathogen
6. Drug to treat alcoholism goal of UH professors research
7. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
8. Louisiana Tech kinesiology professor receives national editorial excellence award
9. WPI computer science professor receives HP Labs Innovation Research Award
10. Linguistics professor examines manufacturers prescription drug websites
11. NJIT professor heads panel studying sudden car acceleration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) ... over the past month! I-829 approvals have been granted to investors in four different ... the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center project ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for a ... a tremendous model of care. One that is very hands on and resident oriented, ... of Monarch Landing. “She’s bringing great passion and energy, as well as a strong ...
(Date:7/29/2015)... ... July 29, 2015 , ... Attorneys representing American families in ... Lawsuit Center. The website now features a page dedicated to news related to pending ... sources. The Talcum Powder Lawsuit News page was launched with eight initial ...
(Date:7/29/2015)... ... 29, 2015 , ... The Woodlands and Spring Fit Body Boot Camps have ... charitable causes each month. The new system will track each time a client uses ... at each facility, the boot camps will donate 20 cents to a selected charity. ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the world’s ... on the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced ... proposal is based on a successful pilot study published in The Journal of ...
Breaking Medicine News(10 mins):Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... program to help students ... influenza prevention,- Detailed curriculum teaches students about influenza and empowers them ... health at home and in their community, CAMBRIDGE, Mass., Sept. ... educational program designed to teach students and,their families about the seriousness ...
... Corporate Partnership Award from the Nevada ... Immunization ... Coalitions,(NIC) today honored Anthem Blue Cross and Blue Shield Partnership ... Anthem received this award as recognition for its efforts to,help ...
... Barriers around informed consent are impeding lifesaving research, experts ... experts have released new recommendations designed to increase the ... are likely to die without treatment. , U.S. law ... risk and agree to participate before they,re enrolled in ...
... University of Illinois at Chicago College of Medicine have ... which seems to reduce clotting without excessive bleeding, the ... reported in the September issue of Molecular and Cellular ... an enzyme whose inhibition lessened platelet aggregation without abnormal ...
... Association of Heart Failure Nurses in Boston, June ... ... Heart,Failure Nurses (AAHFN) 2008 Annual Meeting "Raising the Bar in Heart,Failure Care" ... cutting-edge cardiovascular research and ways to,improve patient care. The compelling agenda ...
... FOR THE PRODUCTION OF ... PRODUCTS USING NATURAL RUBBER LATEX(NRL), ATLANTA, Sept. ... present its revolutionary Vytex(TM) NRL product at,the Latex and ... "Vytex(TM) Natural Rubber Latex: A Proposed Industry Standard for ...
Cached Medicine News:Health News:Launch of New Educational Campaign, Spread the Word - NOT the Flu!, Aims to Highlight Importance of Influenza Vaccination 2Health News:Launch of New Educational Campaign, Spread the Word - NOT the Flu!, Aims to Highlight Importance of Influenza Vaccination 3Health News:Launch of New Educational Campaign, Spread the Word - NOT the Flu!, Aims to Highlight Importance of Influenza Vaccination 4Health News:Anthem Blue Cross and Blue Shield Partnership Plan Wins Nevada Immunization Award 2Health News:Guidelines Seek to Boost Study of Critically Ill 2Health News:Possible safer target for anti-clotting drugs found 2Health News:AAHFN's 2008 Annual Meeting in Boston Will Be 'Raising the Bar in Heart Failure Care' 2Health News:Global Latex Conference to Showcase Vytex(TM) NRL 2
(Date:7/28/2015)... July 28, 2015 A German Diabetes Center ... L. reuteri probiotic enriches human gut microbiota and ... secretion.  The study involved daily administration of Nutraceutix,s ... using the patented BIO- tract ® delivery ... acid on their way to the intestinal tract. ...
(Date:7/28/2015)... , July 28, 2015  PD-Rx Pharmaceuticals, Inc., ... that it has partnered with Dobson Technologies, a ... a Service (IaaS) product. PD-Rx is ... across the United States.  Using Dobson Technologies, IaaS ... and business continuity, ensure regulatory compliance, and reduce ...
(Date:7/28/2015)... , July 28, 2015 At ... Customer Experience Association recognized 15 winners in the ... as applied across multiple vertical markets. ContextMedia:Health ... Deployment Award for its success with its ... ContextMedia:Health, the leading provider of ...
Breaking Medicine Technology:Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2PD-Rx Partners With Dobson Technologies 2ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2
... PHILADELPHIA--(BUSINESS WIRE)--Mar 19, 2007 - Avid,Radiopharmaceuticals, Inc. ... the presentation of the first,results from a ... for positron emission tomography (PET) imaging,of amyloid ... Dr. Christopher Rowe from Austin Hospital of,Melbourne, ...
... Spain, 19 march 2007 - The antidepressant duloxetine, ... non-specific pain,and emotional symptoms associated with depression in ... with at,least moderate pain and major depression. The ... of Psychiatry (AEP),in Madrid, Spain. , Duloxetine, a ...
Cached Medicine Technology:Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 2Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 3Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 4In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 2In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 3In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 4In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 5In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 6
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Silicone Capsule Polisher, 27 g. Silicon tip to provide squeegee effect. Overall length 22 mm. 5/box....
Cystotome Curved, Twisted Tip, 27 g. Twisted tip places cutting edge in line with cannula shaft for vertical cuts during capsulotomies. Overall length 14 mm. 5/box....
Medicine Products: